The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome

被引：0
作者：
Dong Liu
Xue Gao
Xiong-Fei Pan
Tao Zhou
Cairong Zhu
Fei Li
Jian-Gao Fan
Giovanni Targher
Jian Zhao
机构：
[1] Shanghai Jiao Tong University School of Medicine,Ministry of Education and Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital
[2] Shanxi Medical University,Department of Health Statistics, School of Public Health
[3] West China Second University Hospital,Ministry of Education Key Laboratory of Birth Defects and Related Diseases in Women and Children
[4] Sichuan University,Shuangliu Institute of Women’s and Children’s Health
[5] Shuangliu Maternal and Child Health Hospital,School of Public Health (Shenzhen)
[6] Shenzhen Campus of Sun Yat-sen University,West China School of Public Health and West China Fourth Hospital
[7] Sichuan University,Department of Developmental and Behavioral Pediatric & Child Primary Care, Brain and Behavioral Research Unit of Shanghai Institute for Pediatric Research, Xinhua Hospital
[8] Shanghai Jiao Tong University School of Medicine,Department of Maternal and Child Health, School of Public Health
[9] Shanghai Jiao Tong University,Department of Gastroenterology, Xinhua Hospital
[10] Shanghai Jiao Tong University School of Medicine,Section of Endocrinology, Diabetes and Metabolism, Department of Medicine
[11] Shanghai Key Lab of Pediatric Gastroenterology and Nutrition,MRC Integrative Epidemiology Unit
[12] University of Verona,undefined
[13] University of Bristol,undefined
来源：
BMC Medicine | / 21卷
关键词：
Non-alcoholic fatty liver disease; Polycystic ovary syndrome; Mendelian randomization; Fasting insulin; Sex hormones; Hepato-ovarian axis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 255 条
  • [1] Bozdag G(2016)The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod 31 2841-2855
  • [2] Mumusoglu S(2016)Polycystic ovary syndrome N Engl J Med 375 54-64
  • [3] Zengin D(2021)Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017 Hum Reprod 36 1108-1119
  • [4] Karabulut E(2007)Polycystic ovary syndrome Lancet. 370 685-697
  • [5] Yildiz BO(2013)Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 330-344
  • [6] McCartney CR(2017)Management of endocrine disease: polycystic ovary syndrome and nonalcoholic fatty liver disease Eur J Endocrinol 177 R145-RR58
  • [7] Marshall JC(2022)Nonalcoholic fatty liver disease and endocrine axes—a scoping review Metabolites. 12 298-1288
  • [8] Liu J(2018)Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database PLoS Med 15 e1002542-861
  • [9] Wu Q(2017)Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis J Endocrinol Investig 40 1279-585
  • [10] Hao Y(2022)The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 7 851-1586
12345678910